Event Details

Spark Therapeutics, Inc. at the International Society on Thrombosis and Haemostasis (ISTH) 2017 Congress

Monday, July 10, 2017  through Tuesday, July 11, 2017 
Title
Spark Therapeutics, Inc. at the International Society on Thrombosis and Haemostasis (ISTH) 2017 Congress
Date / Time
07/10/17
Description
  • “SPK-9001: Adeno-associated Virus Mediated Gene Transfer for Haemophilia B Achieved Durable Endogenous Prophylaxis at Levels of Activity Sufficient to Achieve Significant Mean Reduction in Annual Bleeding and Infusions Rates in Preliminary Data from an Ongoing Phase 1/2a Trial,” Lindsey George, M.D., on Monday, July 10, from 5:45 to 6 p.m. CET
  • “Gene Therapy Replacement,” Katherine A. High, M.D., on Tuesday, July 11, from 8 to 8:25 a.m. CET
  • “Preliminary Results of SPK-9001 Gene Transfer Demonstrate Statistical Improvements on the Health-related Quality-of-Life in Adults with Haemophilia B Speaker,” Sylvia von Mackensen, Ph.D., poster session on Tuesday, July 11, from 12 to 1:15 p.m. CET